Skip to main content
High RiskFDAfda-F-2137-2017MISLABELED

Cedeira Octopus in Oil Spiced Piquant, Net Weight 4.4oz (125g)

Category
Units Affected
1,008
Recall Date
April 5, 2017
Issuing Agency
Hazard
Mislabeled

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2137-2017.

The product is labeled as Octopus on its label display, while ingredients list Dosidicus Gigas, which is a scientific definition for Jumbo Squid. The firm was informed of this issue by FDA, and voluntarily decided to recall the product, because it appears to be misbranded.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2137-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Malgor & Co., Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2137-2017.

Malgor & Co., Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Malgor & Co., Inc. Recall FAQ

Malgor & Co., Inc. is the subject of a food safety report: Cedeira Octopus in Oil Spiced Piquant, Net Weight 4.4oz (125g). The notice was published on April 5, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 1,008 units are potentially affected.